Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Erin Wechsler"'
Autor:
Felix Chu, Michael Harbell, Amy Manning-Bog, Alexander Scholz, Ngan Nguyen, Norman Greenberg, William Robinson, Daniel Emerling, Tito Serafini, Wei Cao, Yvonne Leung, Nikhil Vad, Anne Ye, Daniel Santos, Cathrin Czupalla, John Vivian, Carlene Williams, Judevin Sapugay, Shaun Lippow, Chantia Carroll, Lance Kates, Benjamin Haugen, Gary Bolton, Mark Armanini, Iraz Aydin, Mark Whidden, Mauricio Velasco-Delgado, Erin Wechsler
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d68b61ac36ac49e5b4d60c03de821131
Autor:
Maryam Bhatti, Michael Weiss, Amanda Haltom, Jessica Finn, Annie Gai, Anne Ye, Danhui Zhang, Cathrin Czupalla, Andreea Stuparu, Yvonne Leung, Erin Wechsler, Iraz Aydin, Daniel Emerling, Amy Manning-Bog, Nikhil Vad, Alexander Scholz, Philippe Marguet, Shaun Lippow
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Alexander Scholz, Jeff DeFalco, Yvonne Leung, Iraz T. Aydin, Cathrin J. Czupalla, Wei Cao, Daniel Santos, Nikhil Vad, Shaun M. Lippow, Gilson Baia, Michael Harbell, Judevin Sapugay, Danhui Zhang, Dai-Chen Wu, Erin Wechsler, Anne Z. Ye, Jenny W. Wu, Xiao Peng, John Vivian, Hargita Kaplan, Rodney Collins, Ngan Nguyen, Mark Whidden, Dongkyoon Kim, Carl Millward, Jonathan Benjamin, Norman M. Greenberg, Tito A. Serafini, Daniel E. Emerling, Lawrence Steinman, William H. Robinson, Amy Manning-Bog
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Immunotherapy approaches focusing on T cells have provided breakthroughs in treating solid tumors. However, there remains an opportunity to drive anticancer immune responses via other cell types, particularly myeloid cells. ATRC-101 was identified vi
Autor:
Norman M. Greenberg, Chantia Carroll, Daniel Emerling, Cathrin J. Czupalla, Iraz T Aydin, Felix Chu, Benjamin Haugen, Shaun M. Lippow, Alexander Scholz, Ngan Nguyen, Nikhil Vad, Yvonne Leung, William H. Robinson, Wei Cao, Lance Kates, Mark Whidden, Gary Bolton, Mark Armanini, Amy Manning-Bog, Tito Serafini, John Vivian, Judevin Lugar Sapugay, Anne Ye, Daniel Santos, Carlene Williams, Michael Harbell, Erin Wechsler, Mauricio Velasco-Delgado
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background We have previously demonstrated adaptive antibody responses targeting public tumor antigens in cancer patients. ATRC-101, a clinical stage, engineered version of an antibody identified in such a patient, displays robust single-agent activi
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A588-A588
BackgroundWe previously described ATRC-101, a fully human, engineered IgG1 antibody which is currently under evaluation in the clinic as a monotherapy for solid tumors. A chimeric version of this antibody expressed on a mouse IgG2a (mATRC-101) has sh